Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Arthritis%22&type=Subject&page=2
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Arthritis%22&type=Subject&page=2
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Arthritis%22&type=Subject&page=2
PubPharm (3.053)
11
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis : A Phase 3 Multicenter, Open-label Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of Subcutaneously Administered Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
12
A Long-term Extension Study of Ustekinumab in Pediatric Participants : A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
13
A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) : A Randomized, Double-Blind, Placebo-Controlled Confirmatory Study of the Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to MTX
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
14
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs : A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
15
A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA : EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) WITH ACTIVE SYSTEMIC FEATURES IN CHILDREN AND ADOLESCENT SUBJECTS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
16
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis : A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
17
Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment : A 28-week, Randomized, Double-blind, Active Controlled, Multicenter Study to Evaluate the Efficacy of Subcutaneously Administered Secukinumab Compared to Ustekinumab in Adult Patients With Psoriatic Arthritis and Failure of TNFα- Inhibitor Treatment (AgAIN)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
18
Cilostazol and Methotrexate in Rheumatoid Arthritis : The Phosphodiesterase 3 Inhibitor Cilostazol as Adjunct to Methotrexate in Patients With Rheumatoid Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
19
An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA) : An Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Efficacy, Safety and Tolerability up to 4 Years in Patients With Juvenile Idiopathic Arthritis Subtypes of Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
20
A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis : A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Reference (Adalimumab) Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[306]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 3
Medienart
3.053
Aufsätze
3.053
E-Artikel
3.053
E-Ressourcen
Zeitschriftentitel
2.484
WHO International Clinical Trials Registry Plat...
569
ClinicalTrials.gov
Thema
3.053
610
Phase: Phase 3
3.053
Study Type: Interventional
1.746
Recruitment Status: Not yet recruiting
536
Recruitment Status: Authorised-recruitment may ...
530
Arthritis
499
Recruitment Status: Completed
368
Arthritis, Rheumatoid
239
Medical Condition: Rheumatoid Arthritis
108
Medical Condition: Moderately to Severely Activ...
104
Arthritis, Psoriatic
95
Recruitment Status: Recruiting
70
Medical Condition: Psoriatic Arthritis MedDRA v...
57
Arthritis, Juvenile
49
Recruitment Status: Terminated
43
Medical Condition: Arthritis, Rheumatoid
42
Medical Condition: Rheumatoid Arthritis MedDRA ...
40
Medical Condition: Moderately to Severely Activ...
36
Medical Condition: Moderately to Severely Activ...
34
Medical Condition: Psoriatic Arthritis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.686
2020-
1.346
2010-2019
21
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.955
Englisch
90
Unbestimmt
8
Spanisch
Haven't found what you're looking for?
Wird geladen...